Muscular Dystrophy Canada in partnership with the Neuromuscular Disease Network for Canada’s Clinical Trial Network is excited to host the final Hope on the Horizon event. This event is geared towards patients and family members within the neuromuscular community.

Join us to learn more about the treatment and clinical trial landscape for Myasthenia Gravis from key experts in the field – Drs. Hans Katzberg, Carolina Barnett-Tapia & Michael Nicolle.

The objectives of this session are as follows:

• To present current clinical practice guidelines and multidisciplinary management strategies for Myasthenia Gravis.
• To provide accessible summaries of ongoing clinical trials, including their purpose, design, and eligibility criteria.
• To introduce promising therapies currently in development and explain their mechanisms and projected timelines.
• To equip individuals and families with tools to make informed choices about care and research participation.
• To strengthen connections between the community and the broader healthcare and research ecosystems.

If you have any questions, please email